{"entity":{"type":"insider","cik":"0001554979","url":"/insider/0001554979","json_url":"/insider/0001554979.json","name":"Pace Megan E","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":11,"first":"2013-07-10","last":"2014-11-19","span_basis":"filed_date"},"name_variants":[{"name":"Pace Megan E","source":"filing","n_filings":11,"first_seen":"2013-07-10","last_seen":"2014-11-19"}],"transactions":[{"id":6272417,"accession":"0001209191-14-069991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-069991","line_url":"/filing/0001209191-14-069991#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33.0,"shares_display":"33","price_per_share":111.93,"price_display":"111.93","price_state":"stated","total_value":3693.69,"total_display":"3,693.69","total_whole":"3,694","shares_owned_after":43350.0,"shares_owned_after_display":"43,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-17","filed_date":"2014-11-19","scope":"insider"},{"id":6877566,"accession":"0001209191-14-060592","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-14-060592","line_url":"/filing/0001209191-14-060592","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56486.0,"shares_display":"56,486","price_per_share":112.67575027440428,"price_display":"112.68","price_state":"stated","total_value":6364602.43,"total_display":"6,364,602.43","total_whole":"6,364,602","shares_owned_after":50379.0,"shares_owned_after_display":"50,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-01","scope":"insider","n_lines":4},{"id":6647811,"accession":"0001209191-14-043875","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-043875","line_url":"/filing/0001209191-14-043875#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12734.0,"shares_display":"12,734","price_per_share":98.03,"price_display":"98.03","price_state":"stated","total_value":1248314.02,"total_display":"1,248,314.02","total_whole":"1,248,314","shares_owned_after":23350.0,"shares_owned_after_display":"23,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2014-06-26","scope":"insider"},{"id":6797463,"accession":"0001209191-14-035067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-035067","line_url":"/filing/0001209191-14-035067","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":369.0,"shares_display":"369","price_per_share":65.65525745257453,"price_display":"65.66","price_state":"stated","total_value":24226.79,"total_display":"24,226.79","total_whole":"24,227","shares_owned_after":23372.0,"shares_owned_after_display":"23,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-15","filed_date":"2014-05-19","scope":"insider","n_lines":2},{"id":7000167,"accession":"0001209191-14-031519","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-031519","line_url":"/filing/0001209191-14-031519","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":67.623,"price_display":"67.62","price_state":"stated","total_value":67623.0,"total_display":"67,623.00","total_whole":"67,623","shares_owned_after":23850.0,"shares_owned_after_display":"23,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-02","filed_date":"2014-05-06","scope":"insider","n_lines":3},{"id":6374704,"accession":"0001209191-14-004556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-004556","line_url":"/filing/0001209191-14-004556#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":106250.0,"total_display":"106,250.00","total_whole":"106,250","shares_owned_after":10100.0,"shares_owned_after_display":"10,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-23","scope":"insider"},{"id":6787696,"accession":"0001209191-14-002375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-002375","line_url":"/filing/0001209191-14-002375#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":838.0,"shares_display":"838","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":62850.0,"total_display":"62,850.00","total_whole":"62,850","shares_owned_after":11350.0,"shares_owned_after_display":"11,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-06","filed_date":"2014-01-08","scope":"insider"},{"id":4427509,"accession":"0001209191-13-056699","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-056699","line_url":"/filing/0001209191-13-056699#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5083.0,"shares_display":"5,083","price_per_share":65.48,"price_display":"65.48","price_state":"stated","total_value":332834.84,"total_display":"332,834.84","total_whole":"332,835","shares_owned_after":12188.0,"shares_owned_after_display":"12,188","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-12","filed_date":"2013-12-12","scope":"insider"},{"id":4461486,"accession":"0001209191-13-053085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-053085","line_url":"/filing/0001209191-13-053085#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93.0,"shares_display":"93","price_per_share":60.97,"price_display":"60.97","price_state":"stated","total_value":5670.21,"total_display":"5,670.21","total_whole":"5,670","shares_owned_after":17271.0,"shares_owned_after_display":"17,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":4602764,"accession":"0001209191-13-036628","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-036628","line_url":"/filing/0001209191-13-036628","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5678.0,"shares_display":"5,678","price_per_share":85.88059175766115,"price_display":"85.88","price_state":"stated","total_value":487630.0,"total_display":"487,630.00","total_whole":"487,630","shares_owned_after":17271.0,"shares_owned_after_display":"17,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-12","filed_date":"2013-07-15","scope":"insider","n_lines":2},{"id":4602731,"accession":"0001209191-13-036628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-036628","line_url":"/filing/0001209191-13-036628#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":84.0,"price_display":"84.00","price_state":"stated","total_value":420000.0,"total_display":"420,000.00","total_whole":"420,000","shares_owned_after":17949.0,"shares_owned_after_display":"17,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-11","filed_date":"2013-07-15","scope":"insider"},{"id":5076176,"accession":"0001209191-13-036102","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-036102","line_url":"/filing/0001209191-13-036102","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001554979","owner_name":"Pace Megan E","owner_display_name":"Pace Megan E","owner_url":"/insider/0001554979","role":"Officer (SVP, Corp. Communications)","role_mark":"O","role_mark_label":"Officer (SVP, Corp. Communications)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Corp. Communications","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28703.0,"shares_display":"28,703","price_per_share":80.88838936696513,"price_display":"80.89","price_state":"stated","total_value":2321739.44,"total_display":"2,321,739.44","total_whole":"2,321,739","shares_owned_after":25449.0,"shares_owned_after_display":"25,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-08","filed_date":"2013-07-10","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (SVP, Corp. Communications)","n_filings":11,"first_seen":"2013-07-10","last_seen":"2014-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001554979","retrieved_at":"2026-08-25T21:09:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}